Efficacy of Herbal Dentifrice for Management of Dentinal Hypersensitivity
Dentinal Hypersensitivity, Chronic Periodontitis
About this trial
This is an interventional treatment trial for Dentinal Hypersensitivity
Eligibility Criteria
Inclusion Criteria: The patient should be in good general health as determined by the Investigator/ medical expert; The patient should agree not to participate in any other oral/dental product studies during the course of this study; The patient should agree to delay any dental treatment until the study has been completed; The patient should agree to abstain from the use of any non-study oral hygiene products; The patient should exhibit adequate oral hygiene (i.e., brush teeth daily and exhibit no signs of oral neglect); The patient should agree to return for all scheduled visits and follow study procedures; The patient should have a minimum of 20 teeth The periodontal status of the patient should be Mild to moderate periodontitis (AAP classification 1999) The oral status of the patient should be as follows: Plaque index (Silness & Löe 1964) >2 Gingival Index (Löe and Silness 1963) >1.5 Modified Sulcus Bleeding Index (Mombelli et al 1987) >1 PPD > 4mm The patient should have two teeth with a Schiff sensitivity score > 1 in response to air challenge. If these two eligible teeth are located in the same quadrant, they have to be separated by one other teeth. Exclusion Criteria: Presence of any condition, abnormality or situation at baseline that in the opinion of the Principal Investigator may preclude the volunteer's ability to comply with study requirements, including completion of the study or the quality of the data Pregnant females Patients having history of Tobacco use Patients with Sjögren's disease Patients having immune deficiency diseases, i.e., HIV or AIDS Patients with poorly controlled diabetes mellitus Patients taking anti TNF-alpha medication for rheumatoid arthritis Patients taking anti-inflammatory, analgesic, or psychotropic drugs, Patients having self-reported eating disorders, uncontrolled gastroesophageal reflux disease (GERD or Acid Reflux), excessive dietary or environmental exposure to acids, or other systemic conditions that are predisposing to dentinal hypersensitivity; Patients with a history or presence of kidney disorders, kidney stones, celiac disease, inflammatory bowel disease (ulcerative colitis or Crohn's disease), chronic pancreatitis, have had intestinal or weight-loss surgery, or if have stomach or intestinal problems that keep them from absorbing certain foods or nutrients; The teeth will be excluded from study measurements if they have deep, defective, or facial restorations; have full crowns, extensive caries, cracked enamel, or are abutment teeth for fixed or removable prosthesis; The teeth having endo-perio lesion.
Sites / Locations
- Dr. D Y Patil dental College and Hospital, Pimpri, PuneRecruiting
Arms of the Study
Arm 1
Arm 2
Arm 3
Experimental
Active Comparator
Placebo Comparator
Group A (Experimental group): (n=25): Curcumin based Jasmate toothpaste preparation
Group B (Positive Control): (n=25): Bioactive glass based BioMin F toothpaste preparation
Group C (Negative Control): (n=25): Placebo toothpaste without any active desensitizing agent
Patients will be instructed to brush twice daily. Patients will be instructed to apply at least a 1-inch strip of the Curcumin based Jasmate toothpaste onto a soft toothbrush and to brush thoroughly for 2 minutes and expectorate. All patients will be instructed to use only the assigned products and refrain from other dentifrice or mouth-rinse during the trial but will be allowed to continue their normal oral hygiene practices. Patients will use the assigned product for a period of 8 weeks for assessment of the efficacy
Patients will be instructed to brush twice daily. Patients will be instructed to apply at least a 1-inch strip of the Biomin F toothpaste (Bioactive glass with Calcium, Phosphate and Fluoride) onto a soft toothbrush and to brush thoroughly for 2 minutes and expectorate. All patients will be instructed to use only the assigned products and refrain from other dentifrice or mouth-rinse during the trial but will be allowed to continue their normal oral hygiene practices. Patients will use the assigned product for a period of 8 weeks for assessment of the efficacy
Patients will be instructed to brush twice daily. Patients will be instructed to apply at least a 1-inch strip of the Placebo toothpaste without any active desensitizing agent onto a soft toothbrush and to brush thoroughly for 2 minutes and expectorate. All patients will be instructed to use only the assigned products and refrain from other dentifrice or mouth-rinse during the trial but will be allowed to continue their normal oral hygiene practices. Patients will use the assigned product for a period of 8 weeks for assessment of the efficacy